-
MTSEA-biotin and the Next Layer of RNA Biology
2026-09-15
Site-specific RNA polymerase II CTD phosphorylation is a regulatory system, not a single transcriptional switch. This thought-leadership perspective explains how MTSEA-biotin can complement FeaSion-style discovery by testing accessibility and conformational hypotheses around candidate CTD regulators, while defining the controls and limitations required for translational confidence.
-
Integrating Transcriptomics and Cardiotoxicity Phenotypes
2026-09-15
Tsai and colleagues developed an integrated screening framework that combines functional, cytotoxicity, transcriptomic, and exposure-oriented analyses in human iPSC-derived cardiomyocytes. Across 464 chemicals, the study shows that transcriptomic points of departure can complement cardiac phenotypes for hazard prioritization and mechanistic interpretation without replacing conventional risk assessment.
-
Doxorubicin Workflows for Cancer and Senescence Models
2026-09-14
Doxorubicin, also known as Adriamycin, is a mechanistically defined benchmark for DNA damage, apoptosis, and drug-response studies. This guide shows how to use it in cancer assays and as a carefully controlled stress-model component when evaluating senolytic or senomorphic nanovesicles.
-
Cell Lysis Strategy for CAF Chemoresistance
2026-09-14
Mechanistic studies of cancer-associated fibroblasts increasingly depend on preserving both protein abundance and protein–protein interactions. This article connects the ANGPTL4–IQGAP1 chemoresistance axis in prostate cancer with practical, translationally oriented protein extraction strategy using Cell lysis buffer for WB and IP.
-
Ceftolozane/Tazobactam: Evidence and Research Insights
2026-09-13
This review examines how ceftolozane/tazobactam combines a PBP-focused cephalosporin with β-lactamase inhibition to address important resistant Gram-negative pathogens. Its value lies in integrating chemistry, microbiology, pharmacokinetics, pharmacodynamics, clinical trials, and safety evidence while defining where activity should not be overgeneralized.
-
Macrophage CCL7 and CRC Immunotherapy Resistance
2026-09-12
The reference study identifies CCL7-producing tumor-associated macrophages as a mechanistic driver of colorectal cancer resistance to immune checkpoint blockade. Its integrated genetic, transcriptomic, proteomic, and flow-cytometric approach links macrophage metabolism with reduced CD8+ T-cell infiltration and provides a rationale for combining CCL7-directed strategies with PD-L1 inhibition.
-
Morning Training Drives Stronger Endurance Adaptation
2026-09-11
A mouse study found that endurance training during the early active phase produced a greater improvement in performance than training during the late active phase, despite lower absolute training volume. The work separates baseline time-of-day performance from training-induced adaptation and links the stronger response to skeletal-muscle remodeling rather than detectable differences in tissue glycogen.
-
Isradipine (Dynacirc) for Calcium-Channel Workflows
2026-09-11
Isradipine (Dynacirc) provides a practical way to probe L-type calcium-channel contributions in vascular, neuronal, and calcium-imaging assays. This guide connects stock preparation and electrophysiology with neuroprotection, vascular smooth muscle relaxation, troubleshooting, and reference-driven channel selectivity.
-
Direct Mouse Genotyping Kit for GEMM Studies
2026-09-10
The Direct Mouse Genotyping Kit connects purification-free PCR amplification from mouse tissue with rigorous genetically engineered mouse model design. Learn how K1025 supports allele verification, colony decisions, and high-throughput genotyping in mesothelioma research while preserving essential assay controls.
-
CTCF, FLG-AS1, and Macrophage Polarization in PDAC
2026-09-10
This study identifies a multilevel regulatory circuit in which CTCF, FLG-AS1, HNRNPU, EP300, IGF2BP2, and CSF1 connect chromatin regulation, RNA modification, alternative splicing, and tumor-associated macrophage polarization in pancreatic ductal adenocarcinoma. The findings provide a mechanistic explanation for how tumor-intrinsic transcriptional regulation can reshape the immune microenvironment and suggest experimental targets for PDAC research.
-
Sodium Orthovanadate: From Signal to Translation
2026-09-09
Sodium Orthovanadate (Na3VO4) is more than a routine phosphatase inhibitor: it is a reversible intervention for protecting phosphorylation-dependent biology while exposing the interpretive risks of broad enzyme inhibition. This article connects its biochemical role to insulin signaling, adipocyte models, assay design, and translational decision-making.
-
Morning Training Improves Endurance Adaptation in Mice
2026-09-09
Hesketh and colleagues show that early-active-phase endurance training produces larger performance gains than late-active-phase training in female mice, even when the early-active group completes less absolute work. The study links this adaptation to selected skeletal-muscle metabolic and contractile changes rather than to measurable differences in muscle or liver glycogen, refining how exercise timing should be interpreted in circadian physiology.
-
QPRT Promotes Breast Cancer Invasion via Myosin Light Chain
2026-09-08
Liu and colleagues show that elevated quinolinate phosphoribosyltransferase (QPRT) is associated with breast cancer invasiveness and promotes migration through a purinergic, Rho–ROCK–PLC–MLCK signaling axis that increases myosin light chain phosphorylation. The study positions QPRT as a mechanistic link between NAD+ metabolism and cytoskeletal remodeling, while also illustrating how pharmacological pathway perturbation can test invasion mechanisms.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-08
This protocol establishes a reproducible whole-blood platform for testing how metabolic interventions alter immune-cell cytokine responses to defined microbial and pattern-recognition receptor stimuli. Its main contribution is methodological: it connects standardized sample handling, controlled stimulation, metabolic perturbation, and cytokine quantification in a format suitable for comparative and cohort-based immunometabolism research.
-
GRA12 and Conserved Toxoplasma Virulence
2026-09-07
This preprint uses pooled in vivo CRISPR-Cas9 screens across Toxoplasma gondii strains and mouse backgrounds to identify virulence factors that remain important across host–parasite combinations. GRA12 emerged as a conserved dense-granule effector that protects the parasitophorous vacuole from immune-associated collapse and premature parasite egress, providing a framework for studying broadly transferable mechanisms of infection.